Cancer Treatment News and Research

RSS

Immunotherapy timing key to survival in small cell lung cancer treatment

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds.

30 Sep 2024

Standard chemoradiation outperforms de-intensified treatments in HPV-associated oropharyngeal cancer

Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III trial after patients in the control arm reached a record high, two-year progression-free survival rate of 98%.

30 Sep 2024

Researchers identify a protein that recharges T cells for long-lasting cancer remission

Research shows Fc–IL-4 revitalizes exhausted CD8+ T cells, boosting antitumor responses and highlighting the potential of combining type 1 and type 2 immunity.

30 Sep 2024

UCLA Health researchers showcase advances in radiation oncology at ASTRO

UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation therapies will present data on the latest radiation oncology research and clinical trial results at the 66th annual American Society for Radiation Oncology (ASTRO) meeting in Washington D.C., Sept. 29 to Oct. 2.

27 Sep 2024

Novel approach combines glutaminase and HuR blockade to suppress breast cancer growth

A study led by Brazilian researchers and reported in an article published in the journal Nature Communications proposes that simultaneously targeting the enzyme glutaminase and the protein HuR, both of which are essential to tumor progression, may be effective in treating breast cancer.

27 Sep 2024

Study reveals rising pharmaceutical industry sponsored clinical trials in the U.S.

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry sponsored clinical trials compared to those conducted with federal government support.

27 Sep 2024

Study reveals positive correlation between type 2 immunity and long-term cancer remission

Results from a preclinical study in mice, led by EPFL, and a collaborative clinical study in patients show that the type 2 immune response – associated with parasitic infection and thought to play a negative role in cancer immunity – is positively correlated with long-term cancer remission.

26 Sep 2024

Older adults face higher CVD risk post-cancer treatment

Older adults treated for cancer face twice the risk of developing cardiovascular diseases compared to those without cancer. The highest risks are seen in patients with metastatic, hematologic, and lung cancers, especially after chemotherapy.

25 Sep 2024

New approach to B-ALL treatment reduces side effects and enhances survival

Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).

24 Sep 2024

Chemotherapy linked to increased cardiovascular risks in older cancer survivors

A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors.

23 Sep 2024

Affordable Care Act boosts colon cancer care for underserved groups in Pennsylvania

The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, patients from rural areas, and patients from the most deprived neighborhoods in Pennsylvania, according to results presented at the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 21-24, 2024.

21 Sep 2024

AI-powered research to advance understanding of radiation exposure risks

Keck Graduate Institute (KGI), a member of The Claremont Colleges, has been awarded a significant grant from the Department of Energy to investigate the effects of low-dose radiation on human beings. The research will advance society's understanding of the collateral and long-term effects of radiation exposure, whether through an individual's vocation or by way of common treatments for certain forms of cancer.

20 Sep 2024

Anti-fibrotic drug shows promise in breast cancer

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of HER2-negative cancers varies among patients, so one goal is to be able to classify tumors in more detail and thus determine the best treatment for each case.

20 Sep 2024

Enhancing patient outcomes with AI-driven intratumoral immunotherapy

A new editorial was published in Oncotarget's Volume 15 on September 17, 2024, entitled, "The emerging role of AI in enhancing intratumoral immunotherapy care."

19 Sep 2024

Access to accredited hospitals improves cancer care outcomes for vulnerable patients

Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than other groups.

19 Sep 2024

Study reveals MYC gene's role in prostate cancer initiation and progression

By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene - a well-known cancer-causing gene - sets off a cascade of events that leads to both initiation and progression of the disease.

19 Sep 2024

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic lymphoma, a rare and slow-growing type of blood cancer, according to a study published recently in Nature Communications.

19 Sep 2024

Researchers seek to revolutionize rectal cancer treatment with AI

With a new four-year, $1.14 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center, will use artificial intelligence (AI) to determine the best personalized treatment for Veterans with rectal cancer.

19 Sep 2024

Researchers discover how oral cancer cells may block the body's immune response

Macquarie University researchers have discovered new information about how oral cancer cells may block the body's immune response. This could lead to better treatments for this aggressive disease.

18 Sep 2024

OU Health Sciences receives major cancer research grant

A $5.3 million National Institutes of Health grant awarded to the University of Oklahoma Health Sciences will support advanced cancer research in Oklahoma. The Centers of Biomedical Research Excellence (COBRE) grant is designed to build research capacity and help early-career researchers establish independently funded laboratories.

18 Sep 2024

Cancer Treatment News and Research

Immunotherapy timing key to survival in small cell lung cancer treatment

Standard chemoradiation outperforms de-intensified treatments in HPV-associated oropharyngeal cancer

Researchers identify a protein that recharges T cells for long-lasting cancer remission

UCLA Health researchers showcase advances in radiation oncology at ASTRO

Novel approach combines glutaminase and HuR blockade to suppress breast cancer growth

Study reveals rising pharmaceutical industry sponsored clinical trials in the U.S.

Study reveals positive correlation between type 2 immunity and long-term cancer remission

Older adults face higher CVD risk post-cancer treatment

New approach to B-ALL treatment reduces side effects and enhances survival

Chemotherapy linked to increased cardiovascular risks in older cancer survivors

Affordable Care Act boosts colon cancer care for underserved groups in Pennsylvania

AI-powered research to advance understanding of radiation exposure risks

Anti-fibrotic drug shows promise in breast cancer

Enhancing patient outcomes with AI-driven intratumoral immunotherapy

Access to accredited hospitals improves cancer care outcomes for vulnerable patients

Study reveals MYC gene's role in prostate cancer initiation and progression

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Researchers seek to revolutionize rectal cancer treatment with AI

Researchers discover how oral cancer cells may block the body's immune response

OU Health Sciences receives major cancer research grant

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News